7/14/2023Bayer to Launch More Innovative Drugs in China

7/5/2023Moderna Set to Make First Investment of $1B in China: Sources

7/5/2023China Offers An Olive Branch to Frustrated MNC Pharma Firms: Reuters

7/5/2023SMEI Forecasts Growth of Ex-Hospital and Innovative Drug Sales Before ...

7/3/2023Innovative Drug Market Share on the Rise Continuously in Recent Years:...

6/26/2023PODCAST: European Businesses Glum on China, and AstraZeneca Weighs Spi...

6/20/2023AstraZeneca's China Head Dismisses Reports of Potential Spinoff as 'Ru...

6/18/2023AstraZeneca Considers Spinning Off of Its China Business: FT

6/15/2023German Businesses Faced Reality Check in China

6/15/2023Swiss Companies Find Renewed Confidence in China's Post-COVID Era

6/15/2023Top Ten Listed Chinese Pharma Companies by R&D Spending in 2021/2022

6/5/2023AstraZeneca Defies Geopolitics to Bet on China (FT)

6/5/2023British Businesses in China: Conditionally Optimistic for 2023 (China ...

6/1/2023The U.S.-Chinese Economic Relationship Is Changing—But Not Vanishing ...

6/1/2023NH's DB6: China's Consumer Healthcare Market Underperformed in 2022

6/1/2023NH's DB6: Top Ten Chinese CHC Brands in 2021

6/1/2023NH's DB6: Chinese Consumer Healthcare Market Forecast 2027/2032

6/1/2023Edelman Report Finds Chinese Trusting Pharma the Most

5/31/2023Sanofi Ups Bet on China with Plan to Enhance Manufacturing and Researc...

5/29/2023A Share-Listed Chinese MedPharm Cos Report Performance in 2022 with Ov...

5/29/2023Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2022

5/22/2023SMEI: Chinese Terminal Drug Market Growth Slowed to 1.1% in 2022 (Upda...

5/19/2023An AstraZeneca Executive Said the Quiet Part about China Out Loud (Qua...

5/18/2023Chinese A Shared-listed Pharma Companies Report Mixed Q1/2023 Performa...

5/16/2023China's Top 10 Homegrown Novel Drugs in 2022, Vaccines and Cancer Drug...

5/5/2023Reshoring and Nearshoring – Is China Still Relevant? (TMD)

5/4/2023AstraZeneca Places Bet on COPD as COVID Vaccine Sales Fade

5/3/2023Getting Novel Drugs to China Through Special Zones (thepharmaletter)

4/28/2023AstraZeneca Eyes More China Deals After Signing Three Licensing Deals

4/26/2023Why Rising Demand for Healthcare Is Creating Investment Opportunities ...

Page:7/39 Total number of articles:1152: [First][<<] [5] [6] [7] [8] [9] [>>] [End]